Highly doubt it is sold through SAS. An only in class drug for OSA won’t be cheap nor should it.
Epydilox (sorry if I have misspelt) was thousands per treatment I believe before it was out on PBS.
Also the reason they go through FDA pathway, so government is picking up the tab.
Also means huge margin.
Highly doubt it is sold through SAS. An only in class drug for...
-
- There are more pages in this discussion • 86 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)